89 related articles for article (PubMed ID: 18211896)
21. Annexin II expression is reduced or lost in prostate cancer cells and its re-expression inhibits prostate cancer cell migration.
Liu JW; Shen JJ; Tanzillo-Swarts A; Bhatia B; Maldonado CM; Person MD; Lau SS; Tang DG
Oncogene; 2003 Mar; 22(10):1475-85. PubMed ID: 12629510
[TBL] [Abstract][Full Text] [Related]
22. Epidermal growth factor modulates prostate cancer cell invasiveness regulating urokinase-type plasminogen activator activity. EGF-receptor inhibition may prevent tumor cell dissemination.
Festuccia C; Angelucci A; Gravina GL; Biordi L; Millimaggi D; Muzi P; Vicentini C; Bologna M
Thromb Haemost; 2005 May; 93(5):964-75. PubMed ID: 15886816
[TBL] [Abstract][Full Text] [Related]
23. Interferon-γ stimulates p11-dependent surface expression of annexin A2 in lung epithelial cells to enhance phagocytosis.
Fang YT; Lin CF; Wang CY; Anderson R; Lin YS
J Cell Physiol; 2012 Jun; 227(6):2775-87. PubMed ID: 21928315
[TBL] [Abstract][Full Text] [Related]
24. Angiogenesis-associated protein annexin II in breast cancer: selective expression in invasive breast cancer and contribution to tumor invasion and progression.
Sharma MR; Koltowski L; Ownbey RT; Tuszynski GP; Sharma MC
Exp Mol Pathol; 2006 Oct; 81(2):146-56. PubMed ID: 16643892
[TBL] [Abstract][Full Text] [Related]
25. Combined affinity labelling and mass spectrometry analysis of differential cell surface protein expression in normal and prostate cancer cells.
Hastie C; Saxton M; Akpan A; Cramer R; Masters JR; Naaby-Hansen S
Oncogene; 2005 Sep; 24(38):5905-13. PubMed ID: 16007208
[TBL] [Abstract][Full Text] [Related]
26. Interferon-inducible protein 9 (CXCL11)-induced cell motility in keratinocytes requires calcium flux-dependent activation of mu-calpain.
Satish L; Blair HC; Glading A; Wells A
Mol Cell Biol; 2005 Mar; 25(5):1922-41. PubMed ID: 15713646
[TBL] [Abstract][Full Text] [Related]
27. S100A10, annexin A2, and annexin a2 heterotetramer as candidate plasminogen receptors.
Kwon M; MacLeod TJ; Zhang Y; Waisman DM
Front Biosci; 2005 Jan; 10():300-25. PubMed ID: 15574370
[TBL] [Abstract][Full Text] [Related]
28. Specific interaction of tissue-type plasminogen activator (t-PA) with annexin II on the membrane of pancreatic cancer cells activates plasminogen and promotes invasion in vitro.
Díaz VM; Hurtado M; Thomson TM; Reventós J; Paciucci R
Gut; 2004 Jul; 53(7):993-1000. PubMed ID: 15194650
[TBL] [Abstract][Full Text] [Related]
29. The ABCA1 transporter modulates late endocytic trafficking: insights from the correction of the genetic defect in Tangier disease.
Neufeld EB; Stonik JA; Demosky SJ; Knapper CL; Combs CA; Cooney A; Comly M; Dwyer N; Blanchette-Mackie J; Remaley AT; Santamarina-Fojo S; Brewer HB
J Biol Chem; 2004 Apr; 279(15):15571-8. PubMed ID: 14747463
[TBL] [Abstract][Full Text] [Related]
30. Differential protein synthesis and expression levels in normal and neoplastic human prostate cells and their regulation by type I and II interferons.
Nagano K; Masters JR; Akpan A; Yang A; Corless S; Wood C; Hastie C; Zvelebil M; Cramer R; Naaby-Hansen S
Oncogene; 2004 Mar; 23(9):1693-703. PubMed ID: 14647428
[TBL] [Abstract][Full Text] [Related]
31. The annexin 2/S100A10 complex controls the distribution of transferrin receptor-containing recycling endosomes.
Zobiack N; Rescher U; Ludwig C; Zeuschner D; Gerke V
Mol Biol Cell; 2003 Dec; 14(12):4896-908. PubMed ID: 13679511
[TBL] [Abstract][Full Text] [Related]
32. Apolipoprotein A-I activates protein kinase C alpha signaling to phosphorylate and stabilize ATP binding cassette transporter A1 for the high density lipoprotein assembly.
Yamauchi Y; Hayashi M; Abe-Dohmae S; Yokoyama S
J Biol Chem; 2003 Nov; 278(48):47890-7. PubMed ID: 12952980
[TBL] [Abstract][Full Text] [Related]
33. Pericellular cathepsin B and malignant progression.
Roshy S; Sloane BF; Moin K
Cancer Metastasis Rev; 2003; 22(2-3):271-86. PubMed ID: 12785001
[TBL] [Abstract][Full Text] [Related]
34. Proteomics in the analysis of prostate cancer.
Naaby-Hansen S; Nagano K; Gaffney P; Masters JR; Cramer R
Methods Mol Med; 2003; 81():277-97. PubMed ID: 12725127
[No Abstract] [Full Text] [Related]
35. Dexamethasone induces rapid serine-phosphorylation and membrane translocation of annexin 1 in a human folliculostellate cell line via a novel nongenomic mechanism involving the glucocorticoid receptor, protein kinase C, phosphatidylinositol 3-kinase, and mitogen-activated protein kinase.
Solito E; Mulla A; Morris JF; Christian HC; Flower RJ; Buckingham JC
Endocrinology; 2003 Apr; 144(4):1164-74. PubMed ID: 12639897
[TBL] [Abstract][Full Text] [Related]
36. Evidence for a role of the adenosine 5'-triphosphate-binding cassette transporter A1 in the externalization of annexin I from pituitary folliculo-stellate cells.
Chapman LP; Epton MJ; Buckingham JC; Morris JF; Christian HC
Endocrinology; 2003 Mar; 144(3):1062-73. PubMed ID: 12586783
[TBL] [Abstract][Full Text] [Related]
37. A PEST sequence in ABCA1 regulates degradation by calpain protease and stabilization of ABCA1 by apoA-I.
Wang N; Chen W; Linsel-Nitschke P; Martinez LO; Agerholm-Larsen B; Silver DL; Tall AR
J Clin Invest; 2003 Jan; 111(1):99-107. PubMed ID: 12511593
[TBL] [Abstract][Full Text] [Related]
38. Sensitization of IFN-gamma Jak-STAT signaling during macrophage activation.
Hu X; Herrero C; Li WP; Antoniv TT; Falck-Pedersen E; Koch AE; Woods JM; Haines GK; Ivashkiv LB
Nat Immunol; 2002 Sep; 3(9):859-66. PubMed ID: 12172544
[TBL] [Abstract][Full Text] [Related]
39. Matrix metalloproteinases and atherosclerotic plaque instability.
Loftus IM; Naylor AR; Bell PR; Thompson MM
Br J Surg; 2002 Jun; 89(6):680-94. PubMed ID: 12027977
[TBL] [Abstract][Full Text] [Related]
40. Interferon-gamma-mediated downregulation of cholesterol efflux and ABC1 expression is by the Stat1 pathway.
Wang XQ; Panousis CG; Alfaro ML; Evans GF; Zuckerman SH
Arterioscler Thromb Vasc Biol; 2002 May; 22(5):e5-9. PubMed ID: 12006410
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]